Sonova Holding AG earnings date
Want to see SONVY full AI Analyst Report?
Sonova Holding AG (SONVY) Q2 2027 Earnings Report
SONVY Q2 2027 EPS Results
- Actual EPS
- $1.24
- Consensus EPS
- $1.08
- Beat/Miss
- Beat by +$0.17
- One Year Ago EPS
- $0.90
SONVY Q2 2027 Revenue Results
- Actual Revenue
- $2.29B
- Expected Revenue
- $2.21B
- Beat/Miss
- Beat by +$80.24M
- YoY Revenue Growth
- +2.56%
Earnings Announcement Details
- Quarter
- Q2 2027
- Date
- 11/12/2026
- Time
- During Market Hours
- Conference Call
- Thursday, November 12, 2026
Sonova Holding AG's next earnings date is estimated for May 18, 2027, based on past reporting schedules.
Q2 2027 Earnings Call Audio
Q2 2027 Earnings Slide Deck
Q2 2027 Earnings Call Summary
The call was strongly positive overall. Sonova reported broad-based sales growth, continued market share gains, significant core EBIT and cash-flow growth, improved returns, strong early product reception and higher full-year guidance. The main challenges were the 10% decline in cochlear implant sales, uncertain U.S. regulatory timing for Integro, slower U.S. and Canadian retail performance, efficiency concerns around sales and marketing spending, discontinued-operation impairment charges and expected market moderation after launch-related stocking. Management nevertheless expressed confidence in continued share gains and execution in the second half.
Sonova now expects global hearing aid market growth of 3% to 5% during the current financial year, consolidated sales growth of 6% to 8% compared with 5% to 8% previously, and core EBIT growth of 10% to 13% compared with 7% to 10% previously; currency translation is expected to be broadly neutral for sales and core EBIT for the full year. The company expects to accelerate strategic investments in the second half by low double-digit CHF million amount, within its midterm 5% to 10% sales growth target, while cochlear implant sales are expected to show an improvement in the second half subject to the timing of regulatory approval in the United States. Sonova remains within its expected CHF 35 million to CHF 40 million for noncore costs, is on track to invest around CHF 80 million to CHF 100 million annually in bolt-on acquisitions, expects CHF 90 million annualized savings and recurring profit improvement by year 4 from CHF 50 million of operational transformation investment, and will remain within its net debt-to-EBITDA corridor of 1x to 1.5x; no share buyback is being considered in the second half.
- Strong First-Half Group PerformanceGroup sales reached CHF 1.8 billion, increasing 7.5% in local currencies and 6.7% in Swiss francs. Organic growth contributed 7 percentage points, M&A contributed 0.5 percentage points, and foreign exchange reduced reported growth by 0.8 percentage points.
- Hearing Instruments Delivered Strong Growth and Margin ExpansionHearing instrument sales increased 9%, core EBIT rose 26%, and the core EBIT margin expanded by 260 basis points to 22%.
- Wholesale Market Share Gains ContinuedWholesale grew 11%, marking 12 months of double-digit growth and 11 consecutive quarters of market share gains. Share in tracked markets moved from the mid-20s to the low 30s percent over that period.
- EON Launch Received Strong Early ResponseEON, which brings real-time AI into a smaller device with superior acoustics, strong connectivity and significantly improved wind performance, had a strong start. Early feedback was described as very positive across markets, with particularly strong demand for higher technology levels and faster-than-expected conversion from Ultra to EON.
- Improved Product Fulfillment and Quality ExecutionEON on-time fulfillment was above 95%, compared with 64% for the earlier Infinio launch. Early complaints were down by more than 1/3 across retail and wholesale.
- Sphere Adoption Was EncouragingAround 2/3 of devices sold globally in the first 2 months were Sphere products. Management expects the mix to normalize over time but to remain above Infinio Ultra.
- Rechargeable In-the-Ear Portfolio Gained ShareVirto R and Insera continued to perform strongly. Sonova reached its fair share quickly in the IT rechargeable category, and share was broadly stable despite competitor launches. Virto R was described as #1 and above 60% share in the U.S. VA category within months of launch.
- Retail Growth and Expansion ContinuedRetail sales grew around 7% in the first half, with more than 5% organic growth and acceleration in the last quarter. M&A activity was picking up, including Høreservice Danmark and Harbor Audiology, and the company remained on track with its retail bolt-on ambition.
- Broad-Based Regional GrowthEMEA and Latin America grew 6.8%, North America grew 7.5%, and Asia Pacific led growth at 11.4%. North American low-double-digit wholesale growth more than offset lower cochlear implant sales, while Asia Pacific hearing instrument growth was in the mid-teens.
- Profitable Asia Pacific MomentumManagement described Asia Pacific growth as profitable and encouraging. China wholesale grew in the double-digit mid-teens, Japan grew north of 20%, and India also grew profitably from a small base. The company is progressing from basic execution improvements toward products designed specifically for Asian needs.
- Gross Margin and Operating Leverage ImprovedCore gross profit increased to CHF 1.4 billion and core gross margin reached 74.7%, an improvement of around 230 basis points in local currency. Core operating expenses grew 6.9%, slightly below sales growth.
- Core EBIT and EPS Growth Were StrongCore EBIT increased 22.9% to CHF 384 million, with the core EBIT margin reaching 20.9% versus 18.4% a year ago, a 260-basis-point expansion. Core EPS increased 38% to CHF 5.37, while reported EPS was CHF 5.18.
- Cash Generation and Returns ImprovedOperating cash flow increased to CHF 378 million. Operating free cash flow rose to CHF 287 million from CHF 90 million, and free cash flow reached CHF 266 million versus CHF 60 million a year ago. ROCE increased to 20.9% from 19.5%, while net debt-to-EBITDA was 1.1x.
- Operational Transformation Has Defined Savings TargetThe company committed CHF 50 million of investment in its operational transformation program and remains on track to deliver CHF 90 million of annualized savings and recurring profit improvement by year 4.
- Strategic Investments Are Being AcceleratedSonova plans to increase strategic investments in the second half by a low double-digit CHF million amount within core operating expenses. The investments cover R&D, manufacturing and supply chain capabilities, digital systems, IT productivity and resilience, and improvements to the consumer journey.
- Full-Year Guidance Was RaisedFull-year consolidated sales growth guidance was raised to 6% to 8% from 5% to 8%. Core EBIT growth guidance was raised to 10% to 13% from 7% to 10%. The global hearing aid market growth assumption was increased to 3% to 5% from the previous expectation of 2% to 4%.
- Employee Engagement ImprovedEmployee engagement reached 74%, up 6 percentage points from the December 2025 baseline. More than 90% of employees understood the behaviors required to execute the refined strategy.
- Disciplined Capital Allocation and M&A PipelineSonova had invested approximately CHF 50 million in retail bolt-on acquisitions by October and remained on track to invest around CHF 80 million to CHF 100 million annually. Management emphasized that deals must meet hurdles for strategic fit, valuation and returns.
SONVY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 18, 2027 | 2027 (Q4) | 1.57- | 1.44 | ― | ― |
| Nov 12, 2026 | 2027 (Q2) | 1.071.24 | 0.9 | 38.35% (+0.34) | |
| May 18, 2026 | 2026 (Q4) | 1.441.44 | 1.71 | -15.65% (-0.27) | |
| Nov 14, 2025 | 2026 (Q2) | 0.980.90 | 0.85 | 5.78% (+0.05) | |
| May 09, 2025 | 2025 (Q4) | 1.361.71 | 1.29 | 32.35% (+0.42) | |
| Nov 19, 2024 | 2025 (Q2) | 0.870.85 | 0.98 | -13.82% (-0.14) | |
| May 14, 2024 | 2024 (Q4) | 1.171.29 | 1.3 | -0.77% (-0.01) | |
| Nov 21, 2023 | 2024 (Q2) | 0.930.98 | 1.04 | -5.02% (-0.05) | |
| May 16, 2023 | 2023 (Q4) | 1.241.30 | 1.11 | 17.45% (+0.19) | |
| Nov 14, 2022 | 2023 (Q2) | 0.961.04 | 1.05 | -1.71% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


